NR293 - Nursing Application: Hormonal Regulation Drugs |
UPDATED Questions with 100% Verified Answers
Chamberlain University-Illinois • NR 293
Q1: Which client is most likely to be taking somatropin?
A: A client with growth failure
Q2: Octreotide Mechanism of Action
A: Octreotide suppresses the secretion of serotonin, increases the absorption of fluid and electrolytes from the GI tract,
and increases GI transit time.
Q3: The nurse is caring for a client who has been diagnosed with Graves' disease and started on an
antithyroid medication Which medication is most likely to be prescribed?
A: Methimazole
Q4: The client may experience which adverse reaction of this antithyroid medication (methimazole)?
A: Agranulocytosis
Q5: In a client receiving methimazole, which laboratory test is needed to monitor for agranulocytosis?
A: Complete blood count
UPDATED Questions with 100% Verified Answers
Chamberlain University-Illinois • NR 293
Q1: Which client is most likely to be taking somatropin?
A: A client with growth failure
Q2: Octreotide Mechanism of Action
A: Octreotide suppresses the secretion of serotonin, increases the absorption of fluid and electrolytes from the GI tract,
and increases GI transit time.
Q3: The nurse is caring for a client who has been diagnosed with Graves' disease and started on an
antithyroid medication Which medication is most likely to be prescribed?
A: Methimazole
Q4: The client may experience which adverse reaction of this antithyroid medication (methimazole)?
A: Agranulocytosis
Q5: In a client receiving methimazole, which laboratory test is needed to monitor for agranulocytosis?
A: Complete blood count